Monitor the pace of share issuance through the ATM program, as rapid sales could pressure the stock price. The company's cash runway has been extended significantly by recent financing, reducing near-term funding risk.
Price Chart
Executive Summary
Century Therapeutics is conducting an at-the-market (ATM) offering of up to $131.6 million in common stock through TD Cowen, following a recent $135 million private placement. The proceeds will fund research, clinical development, and general corporate purposes. This offering follows significant recent capital raising and results in immediate dilution for new investors.
Key Facts
- Offering up to $131.6 million in common stock through an at-the-market offering with TD Cowen
- Recent $135 million private placement completed in January 2026
- Net tangible book value of $1.40 per share after private placement, with offering price at $2.07
- Immediate dilution of $0.51 per share to new investors
- Proceeds to be used for research, clinical development, and general corporate purposes
Financial Impact
Up to $131.6 million in gross proceeds, with net proceeds after 3% commission and $279,000 in expenses
Risk Factors
- Dilution to existing shareholders as new shares are issued
- Potential downward pressure on stock price if shares are sold rapidly in the ATM program
- Market perception of the company needing additional capital despite recent financing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001104659-26-035255 |
| Document: 0001104659-26-035255-index-headers.html | 0001104659-26-035255 |
| Document: 0001104659-26-035255-index.html | 0001104659-26-035255 |
| Document: 0001104659-26-035255.txt | 0001104659-26-035255 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 2, 2026 25d ago | 8-K | $1.53 $1.48 | ▼ −3.27% | ▼ −3.94% | $1.45 (−5.23%) |
Oct 2, 2026 25d ago | Press Release | $1.53 $1.48 | ▼ −3.27% | ▼ −3.94% | $1.45 (−5.23%) |
Sep 22, 2026 5w ago | Institutional Cluster | $1.89 $1.76 | ▼ −6.88% | ▼ −6.16% | $1.45 (−23.28%) |
Sep 10, 2026 6w ago | 3 | $1.94 $2.00 | ▲ +3.09% | ▲ +3.54% | $1.45 (−25.26%) |
Aug 12, 2026 10w ago | 8-K | $1.96 $1.93 | ▼ −1.53% | ▼ −2.23% | $1.45 (−26.02%) |
Aug 12, 2026 10w ago | Press Release | $1.96 $1.93 | ▲ +1.53% | ▲ +2.23% | $1.45 (+26.02%) |
Jun 16, 2026 19w ago | 8-K | $2.25 $2.29 | ▲ +1.78% | ▲ +1.00% | $1.45 (−35.56%) |
Jun 15, 2026 19w ago | Insider Cluster | $2.18 $2.25 | ▲ +3.21% | ▲ +4.46% | $1.45 (−33.49%) |
Jun 9, 2026 20w ago | Insider Cluster | $2.12 $2.24 | ▲ +5.66% | ▲ +3.96% | $1.45 (−31.60%) |
Jun 9, 2026 20w ago | Insider Cluster | $2.12 $2.24 | ▲ +5.66% | ▲ +3.96% | $1.45 (−31.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers